4
Changes in Ownership
Serina Therapeutics, Inc. Filed Acc 0001301120-26-000008
Chief Scientific Officer sold 2,500 shares at $2.95 ($7,375)
- Chief Scientific Officer acquired 2,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Moreadith Randall · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-22 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,500 | $0.06 | $150 | 2,500 | D |
| 2026-01-22 | Sale : show line 2 in the form 10b5-1 | −2,500 | $2.95 | $7,375 | 0 | D |
| Open-market sales · 2,500 sh · avg $2.95 · $7,375 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-22 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) | −2,500 | 326,186 | D |
Loading xslF345X05/wk-form4_1769189706.xml…